Erythropoietin Drugs Market Estimated to Reach USD 14.3 billion, Advancing at a CAGR of 3.8% by 2034: Transparency Market Research Inc. [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The global erythropoietin drugs market is estimated to surge at a CAGR of 3.8% from 2024 to 2034. Transparency Market Research projects that the overall sales revenue for erythropoietin drugs is estimated to reach US$ 14.3 billion by the end of 2034. With advancements in precision medicine, there's a growing emphasis on tailoring erythropoietin therapy to individual patient characteristics, optimizing treatment efficacy and minimizing adverse effects. Ongoing regulatory reforms aimed at streamlining approval processes for biosimilars and biologics are fostering market competition and driving down costs, enhancing accessibility to erythropoietin therapy for patients globally. The integration of telemedicine platforms enables remote monitoring of patients receiving erythropoietin therapy, facilitating timely adjustments to dosage regimens and enhancing patient adherence, p
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie [Yahoo! Finance]Yahoo! Finance
- Amgen (AMGN) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Is Amgen Inc. (NASDAQ:AMGN) Trading At A 42% Discount? [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 8/6/24 - Beat
AMGN
Sec Filings
- 8/13/24 - Form 4
- 8/13/24 - Form 4
- 8/13/24 - Form 4
- AMGN's page on the SEC website